Princeton University is uniting with institutions on a new project aimed at advancing cancer immunotherapy. The Weill Cancer Hub East, launched with a $50 million donation from the Weill Family Foundation, involves collaborations with The Rockefeller University, Weill Cornell Medicine, and the Ludwig Institute for Cancer Research. The joint effort seeks to raise the total investment to more than $125 million, with philanthropy from partner institutions.
Joan and Sanford I. Weill announced the partnership, bringing together leading experts to explore the connections between nutrition, metabolism, and immunotherapy. By combining resources and expertise, the hub intends to enhance immunotherapy’s effectiveness and improve cancer patient care.
Sanford “Sandy” Weill stated, “With the best minds in the field armed with the most advanced research techniques, the Weill Cancer Hub East will seek to elevate immunotherapy and improve patient care for people battling cancer.”
Princeton University President Christopher L. Eisgruber emphasized the collaboration’s potential to drive scientific breakthroughs, saying, “This unprecedented partnership in our region’s biomedical innovation ecosystem has the potential to speed cures and treatments where they are most needed.”
The hub will cover key research areas, such as how diet and gut microbiome impact immunotherapy success, and will investigate how lifestyle changes can improve treatment outcomes. Joshua Rabinowitz, who will lead Princeton’s participation, noted, “We have to do whatever we can, scientifically, to find solutions for patients.”
Research will also assess how GLP-1 agonists, drugs used for diabetes and obesity, might impact cancer progression and treatment. Weill Cornell Medicine’s Dr. Robert A. Harrington highlighted the importance of understanding immunotherapy’s effectiveness, stating, “By convening world-class institutions with leading investigators in their respective fields, … the Weill Cancer Hub East seeks to discover new ways that nutrition and gut microbes can improve the immune response to the disease.”
A dedicated scientific steering committee, featuring experts from each institution, including Princeton’s Rabinowitz, will guide the hub’s scientific activities. The initiative will also involve a leadership committee, providing strategic oversight and ensuring its adaptability to future cancer research developments.
“The Weill Cancer Hub East has enormous potential to transform the way we treat cancer and change the world,” said Sandy Weill, underscoring the broader impact envisioned by supporters.
